What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?

被引：54

作者：

Ahrens, Ingo ^{[1
]}

Lip, Gregory Y. H. ^{[2
]}

Peter, Karlheinz ^{[3
]}

机构：

[1] Univ Klin, D-79106 Freiburg, Germany

[2] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England

[3] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia

来源：

THROMBOSIS AND HAEMOSTASIS | 2011年 / 105卷 / 04期

关键词：

DABIGATRAN; WARFARIN; SAFETY; RIVAROXABAN; RATIONALE; INHIBITOR; APIXABAN; EFFICACY; DESIGN;

D O I：

10.1160/TH10-12-0808

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：574 / 578

页数：5

共 24 条

[1] New oral anticoagulant drugs in cardiovascular disease [J].

Ahrens, Ingo ;

Lip, Gregory Y. H. ;

Peter, Karlheinz .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :49-60

[2]

[Anonymous], FDA APPR DAB STROK P

[3]

[Anonymous], ORBIT ROCKET AF RIVA

[4]

Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]

[5] Newly Identified Events in the RE-LY Trial [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Reilly, Paul A. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876

[6] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[7] Atherothrombosis and atrial fibrillation: Important and often overlapping clinical syndromes [J].

Depta, Jeremiah P. ;

Bhatt, Deepak L. .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (04) :657-663

[8]

Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X

[9] Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment [J].

Eikelboom, John W. ;

O'Donnell, Martin ;

Yusuf, Salim ;

Diaz, Rafael ;

Flaker, Greg ;

Hart, Robert ;

Hohnloser, Stefan ;

Joyner, Campbell ;

Lawrence, Jack ;

Pais, Prem ;

Pogue, Janice ;

Synhorst, David ;

Connolly, Stuart J. .

AMERICAN HEART JOURNAL, 2010, 159 (03) :348-U38

[10] Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin [J].

Eisert, Wolfgang G. ;

Hauel, Norbert ;

Stangier, Joachim ;

Wienen, Wolfgang ;

Clemens, Andreas ;

van Ryn, Joanne .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (10) :1885-1889

← 1 2 3 →